Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics

Journal of Pharmaceutical Sciences

Volumn 86, Issue 3, 1997, Pages 323-328

  Kim, Hyunjo ^a   Fassihi, Reza ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DILTIAZEM; NIFEDIPINE; POLYMER; THEOPHYLLINE DERIVATIVE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG RELEASE; DRUG SOLUBILITY; FLOW RATE; HYDRODYNAMICS;

EID: 0031041730     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js960307p     Document Type: Article

References (36)

1. Conte, U.; Colombo, P.; Gazzaniga, A.; Sangalli, M. E.; Lamanna, A. Biomaterials 1988, 9, 489-493.
2. Conte, U.; Maggi, L.; Lamanna, A. S. T. P. J. Pharm. Sci. 1994, 4, 107-113.
3. Lee, P. I.; Peppas, N. A. J. Controlled Release 1987, 6, 207-215.
4. Colombo, P. Adv. Drug Deliv. Rev. 1993, 11, 37-57.
5. Conte, U.; Colombo, P.; Maggi, L.; Lamanna, A. J. Controlled Release 1993, 26, 39-47.
6. Conte, U.; Maggi, L.; Lamanna, A. Proc. Int. Symp. Controlled Release Bioact. Mater. 1993, 20, 350-351.
7. Harland, R. S.; Gazzaniga, A.; Colombo, P.; Edvige Sangalli, M.; Peppas, N. A. Pharm. Res. 1988, 5, 488-494.
8. Korsmeyer, R. W.; Gurny, R.; Doelker, E.; Buri, P.; Peppas, N. A. Int. J. Pharm. 1983, 15, 25-35.
9. Rao, K. V. R.; Devi, K. P.; Buri, P. J. Controlled Release 1990, 12, 133-141.
10. Katikaneni, P. R.; Upadrashta, S. M.; Neau, S. H.; Mitra, A. K. Int. J. Pharm. 1995, 123, 119-125.
11. Barochez, B. H.; Julien, J. S.; Lapeyre, F.; Horvath, S.; Adrix, A. C.; Vignat, E. Drug Dev. Ind. Pharm. 1989, 15, 2197-2212.
12. Yang, L.; Fassihi, A. R. J. Pharm. Sci. 1996, 85, 170-173.
13. Kim, C. J. J. Pharm. Sci. 1995, 84, 303-306.
14. Parsonage, E.; Lee, P. I.; Peppas, N. A. J. Vac. Sci. Techn. Part B 1987, 5, 538-545.
15. Lee, P. I. J. Memb. Sci. 1980, 7, 256-275.
16. Colombo, P.; Bettini, R.; Massimo, G.; Catellani, P. L.; Santi, P.; Peppas, N.A. J. Pharm. Sci. 1995, 84, 991-997.
17. Schott, H. J. Pharm. Sci. 1992, 5, 467-470.
18. Lindner, W. D.; Lippold, B. C. Pharm. Res. 1995, 12, 1781-1785.
19. Rajabi-Siahboomi, A. R.; Bowtell, R. W.; Mansfield, P.; Davies, M. C.; Melia, C.D. Pharm. Res. 1996, 13, 376-380.
20. Kim, H.; Fassihi, R., submitted for publication in Pharm. Res.
21. Kim, H.; Fassihi, R. 1997, 86, 316-322 (preceding paper in this issue). J. Pharm. Sci.
22. Ritger, P. L.; Peppas, N. A. J. Controlled Release 1986, 5, 37-42.
23. Wolfram, D. L.; Bernhard, C. L. Pharm. Res. 1995, 12, 1781-1785.
24. Handbook on METHOCEL Premium Cellulose Ethers; The Dow Chemical Company, 1995.
25. Daly, P. B.; Davis, S. S.; Kennerley, J. W. Int. J. Pharm. 1984, 18, 201-205.
26. Voegele, D.; Brockmeier, D.; Hattingberg, H. M.; Lippold, B. C. Acta Pharm. Technol. 1983, 29, 167-174.
27. Lee, P. T.; Peppas, N. A. J. Controlled Release 1987, 6, 471-477.
28. Gao, P.; Skoug, J. W.; Nixon, P. R.; Ju, T. R.; Stemm, N. L.; Sung, K. C. J Pharm. Sci. 1996, 85, 732-740.
29. Colombo, P.; Bettini, R.; Santi, P.; Ascentiis, A.; Peppas, N. A. J. Controlled Release 1996, 39, 231-237.
30. Bettini, R.; Colombo, P.; Massimo, G.; Catellani, P. L.; Vitali, T. Eur. J. Pharm. Sci. 1994, 2, 213-219.
31. Mitchell, K.; Ford, J. L.; Armstrong, D. J.; Elliot, P. N. C.; Hogan, J. E.; Rostron, C. Int. J. Pharm. 1993, 100, 165-173.
32. SUPAC guidance for industry: Immediate release solid oral dosage forms; Center for Drug Evaluation and Reserch, FDA; November, 1995.
33. Lapidus, H.; Lordi, N. G. J. Pharm. Sci. 1968, 57, 1292-1310.
34. Lindner, W. D.; Mockel, J. E.; Lippold, B. C. Eur. J. Pharm. Biopharm. 1995, 84, 991-997.
35. Ford, J. L.; Rubinstein, M. H.; Hogan, Int. J. Pharm. 1985, 24, 339-350.
36. Wan, L. S. C.; Heng, L. F. Drug. Del. Ind. Pharm. 1993, 19, 1201-1210.